2025 Updates in the Management of SMM/MGUS and the Prevention of Progression
Dana-Farber Cancer Institute via YouTube
The Most Addictive Python and SQL Courses
AI Adoption - Drive Business Value and Organizational Impact
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
In this 25-minute presentation from Dana-Farber Cancer Institute, Dr. Yuxin Liu provides comprehensive updates on managing plasma cell precursor conditions, focusing on smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS). Discover the latest developments in prevention strategies for disease progression, including current research findings and treatment approaches. Gain valuable insights into early detection methods and intervention techniques for these blood cancer precursor conditions. The talk offers specialized knowledge for healthcare professionals working with patients at risk of developing multiple myeloma and related disorders. For more information about early detection and interception of blood cancers, viewers can explore Dana-Farber's dedicated center resources.
Syllabus
2025 Updates in the Management of SMM/MGUS and the Prevention of Progression
Taught by
Dana-Farber Cancer Institute